Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

OLR1 Antikörper (Soluble)

OLR1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal unconjugated
Produktnummer ABIN639899
  • Target Alle OLR1 Antikörper anzeigen
    OLR1 (Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1))
    Bindungsspezifität
    • 16
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Soluble
    Reaktivität
    • 60
    • 25
    • 22
    • 18
    • 2
    Human
    Wirt
    • 40
    • 23
    • 2
    • 2
    • 1
    • 1
    Maus
    Klonalität
    • 45
    • 24
    Monoklonal
    Konjugat
    • 37
    • 6
    • 4
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser OLR1 Antikörper ist unkonjugiert
    Applikation
    • 46
    • 28
    • 21
    • 13
    • 13
    • 13
    • 11
    • 9
    • 8
    • 7
    • 6
    • 4
    • 3
    • 3
    • 1
    • 1
    Western Blotting (WB), ELISA
    Verwendungszweck
    Mouse Anti-Human LOX-1 (soluble)
    Spezifität
    DS-MB-03380 recognizes the lectin-like oxidised low-density lipoprotein (LDL) receptor (LOX-1), a 31kDa protein of the C-type lectin superfamily. This receptor mediates the recognition, internalization and degradation of oxidized LDL. It is a Type II membrane protein with a typical C-type lectin structure at the extracellular C-terminus which recognizes the ligand. LOX-1 activation by oxidized LDL causes endothelial changes such as decreased nitric oxide release and an increased expression of adhesion molecules. LOX-1 also binds activated platelets and apoptotic cells. The expression of LOX-1 is induced by proatherogenic conditions such as hyperlipidemia, hypertension and diabetes and as such appears to contribute to the pathogenesis of vascular disorders, particularly atherosclerosis. It can be cleaved by an unknown protease at the extracellular juxtamembrane region to release the soluble form (aa58-273) of LOX-1, recognized by DS-MB-03380
    Aufreinigung
    Purified
    Immunogen
    Recombinant soluble LOX-1 expressed in E.coli.
    Isotyp
    IgG1
    Top Product
    Discover our top product OLR1 Primärantikörper
  • Applikationshinweise
    ELISA, Western Blotting
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    IgG concentration 1.0 mg/ml
    Buffer
    Phosphate buffered saline pH7.4
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    -20°C
  • Target
    OLR1 (Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1))
    Andere Bezeichnung
    LOX-1 (OLR1 Produkte)
    Synonyme
    OLR1 antikoerper, LOX1 antikoerper, Olr1 antikoerper, CLEC8A antikoerper, LOXIN antikoerper, SCARE1 antikoerper, SLOX1 antikoerper, LOX-1 antikoerper, SR-EI antikoerper, Scare1 antikoerper, Oldlr1 antikoerper, Oldr1 antikoerper, PLOX-1 antikoerper, oxidized low density lipoprotein receptor 1 antikoerper, oxidized low density lipoprotein (lectin-like) receptor 1 antikoerper, OLR1 antikoerper, Olr1 antikoerper
Sie sind hier:
Kundenservice